Search

everythinglearnresearchcommunity

for

Search:↓

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Fucoidan reduces bone cell formation by affecting T-cell activity.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Certain genetic factors may contribute to frontal fibrosing alopecia in Brazil.

Potential therapeutic targets for scarring hair loss are identified.

Increased T cell activity may predict hair regrowth success with minoxidil in severe alopecia areata.

Different γδ T cell types have unique roles in causing alopecia areata.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Hydrogel scaffolds can help wounds heal better and grow hair.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Staphylococcus aureus affects immune responses and skin cells in atopic dermatitis, suggesting new treatment targets.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

Langerhans cells are crucial for skin immunity and allergic reactions.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.